Financial Summary (All financials)
In millions, except per share items | Jan-29-23 | Jan-30-22 | Jan-31-21 | Feb-02-20 | Feb-03-19 |
Revenues | 6,651 | 5,004 | 3,642 | 3,389 | 3,202 |
Revenue growth | 32.9% | 37.4% | 7.5% | 5.9% | |
Cost of goods sold | 4,856 | 3,724 | 2,764 | 2,600 | 2,494 |
Gross profit | 1,795 | 1,280 | 878 | 789 | 708 |
Gross margin | 27.0% | 25.6% | 24.1% | 23.3% | 22.1% |
Selling, general and administrative | 917 | 744 | 576 | 527 | 458 |
EBITA | 895 | 545 | 303 | 262 | 234 |
EBITA margin | 13.5% | 10.9% | 8.3% | 7.7% | 7.3% |
Amortization of intangibles | 120 | 120 | 118 | 107 | 96 |
EBIT | 775 | 425 | 185 | 155 | 138 |
EBIT margin | 11.7% | 8.5% | 5.1% | 4.6% | 4.3% |
Pre-tax income | 709 | 276 | 46 | 42 | 37 |
Income taxes | 128 | 51 | 9 | 6 | 7 |
Tax rate | 18.1% | 18.5% | 19.6% | 14.3% | 18.8% |
Net income | 366 | 166 | 37 | 36 | 30 |
Net margin | 5.5% | 3.3% | 1.0% | 1.1% | 0.9% |
|
Diluted EPS | $1.49 | $0.68 | | | |
Shares outstanding (diluted) | 246 | 244 | | | |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|